High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis

about

High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis

Item

http://www.wikidata.org/entity/Q37662632

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

High levels of serum platelet- ...... rectal cancer liver metastasis

@en

High levels of serum platelet- ...... ectal cancer liver metastasis.

@nl

type

Item

label

High levels of serum platelet- ...... rectal cancer liver metastasis

@en

High levels of serum platelet- ...... ectal cancer liver metastasis.

@nl

prefLabel

High levels of serum platelet- ...... rectal cancer liver metastasis

@en

High levels of serum platelet- ...... ectal cancer liver metastasis.

@nl

P1476

High levels of serum platelet- ...... rectal cancer liver metastasis

@en

P2093

Gang Xiao

http://www.w3.org/2001/XMLSchema#string

Hong-Da Pan

http://www.w3.org/2001/XMLSchema#string

Jin Gu

http://www.w3.org/2001/XMLSchema#string

Yi-Fan Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.

HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Revised TN categorization for colon cancer based on national survival outcomes data.

Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes

PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors

HER2/neu testing in primary colorectal carcinoma.

P304

1233-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I7.1233

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275303

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5323448

http://www.w3.org/2001/XMLSchema#string